Migraine Drugs Market: Key Findings, Executive Summary, Investment Pockets, and Regional Analysis | AMR
♦ 𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐅𝐫𝐞𝐞 𝐒𝐚𝐦𝐩𝐥𝐞 𝐏𝐃𝐅 𝐑𝐞𝐩𝐨𝐫𝐭:
Here is some more information about migraine drugs:
1. Triptans: There are several types of triptans, including sumatriptan, rizatriptan, and zolmitriptan. These drugs work by stimulating serotonin receptors in the brain, which can help reduce inflammation and relieve migraine symptoms. They are available in various forms, including tablets, nasal sprays, and injections. Some potential side effects of triptans include dizziness, drowsiness, and tingling or numbness in the hands or feet.
2. Ergotamines: These drugs, including ergotamine and dihydroergotamine, work by constricting blood vessels in the brain and reducing inflammation. They are available in tablet, nasal spray, and injection forms. Ergotamines should not be used in combination with triptans, as this can increase the risk of serious side effects, such as heart attack or stroke.
3. Nonsteroidal anti-inflammatory drugs (NSAIDs): NSAIDs, such as ibuprofen and naproxen, can be effective in treating mild to moderate migraines. They work by reducing inflammation and pain. These drugs are available over-the-counter and in prescription-strength formulations.
4. Beta blockers: Beta blockers, such as propranolol and metoprolol, are typically used to treat high blood pressure and other cardiovascular conditions, but they can also be effective in preventing migraines. These drugs work by reducing the frequency and severity of migraines. Potential side effects of beta blockers include fatigue, dizziness, and sexual dysfunction.
5. Antidepressants: Antidepressants, such as amitriptyline and venlafaxine, are sometimes used to prevent migraines, particularly in people who also have depression or anxiety. These drugs work by altering levels of serotonin and other neurotransmitters in the brain. Potential side effects of antidepressants include dry mouth, weight gain, and sexual dysfunction.
6. Anti-seizure drugs: Anti-seizure drugs, such as topiramate and valproate, are sometimes used to prevent migraines, particularly in people who also have epilepsy. These drugs work by reducing the activity of certain neurotransmitters in the brain. Potential side effects of anti-seizure drugs include dizziness, nausea, and fatigue.
♦ 𝐏𝐫𝐨𝐜𝐮𝐫𝐞 𝐂𝐨𝐦𝐩𝐥𝐞𝐭𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 (𝟐𝟐𝟎 𝐏𝐚𝐠𝐞𝐬 𝐏𝐃𝐅 𝐰𝐢𝐭𝐡 𝐈𝐧𝐬𝐢𝐠𝐡𝐭𝐬, 𝐂𝐡𝐚𝐫𝐭𝐬, 𝐓𝐚𝐛𝐥𝐞𝐬, 𝐚𝐧𝐝 𝐅𝐢𝐠𝐮𝐫𝐞𝐬) @ https://www.alliedmarketresearch.com/checkout-final/2e8d091280b3fa66939c955dba9820d8
𝗜𝗺𝗽𝗼𝗿𝘁𝗮𝗻𝘁 𝗞𝗲𝘆 𝗠𝗮𝗿𝗸𝗲𝘁 𝗣𝗹𝗮𝘆𝗲𝗿𝘀 𝗔𝗿𝗲 -
• Abbott Laboratories,
• Allergan Plc.,
• Eisai Co., Ltd.,
• Endo International Plc.,
• GlaxoSmithKline Plc.,
• Impax Laboratories,
• Johnson & Johnson,
• Merck & Co., and
• Pfizer Inc.
𝗞𝗲𝘆 𝗙𝗶𝗻𝗱𝗶𝗻𝗴𝘀 𝗼𝗳 𝗧𝗵𝗲 𝗦𝘁𝘂𝗱𝘆 -
• North America occupied two-fifths share of the global migraine drugs market.
• Oral is anticipated to grow with the highest CAGR throughout the forecast period.
• Asia-Pacific is anticipated to grow at the highest rate during the analysis period, followed by LAMEA.
♦ 𝐅𝐨𝐫 𝐏𝐮𝐫𝐜𝐡𝐚𝐬𝐞 𝐈𝐧𝐪𝐮𝐢𝐫𝐲 𝐨𝐟 𝐑𝐞𝐩𝐨𝐫𝐭:
𝗚𝗲𝗼𝗴𝗿𝗮𝗽𝗵𝗶𝗰 𝗦𝗲𝗴𝗺𝗲𝗻𝘁𝘀 𝗖𝗼𝘃𝗲𝗿𝗲𝗱 𝗶𝗻 𝘁𝗵𝗲 𝗥𝗲𝗽𝗼𝗿𝘁 -
The Migraine Drugs Market report provides information about the market area, which is further subdivided into sub-regions and countries/regions. In addition to the market share in each country and sub-region, this chapter of this report also contains information on profit opportunities. This chapter of the report mentions the market share and growth rate of each region, country, and sub-region during the estimated period.
• North America (USA and Canada)
• Europe (UK, Germany, France and the rest of Europe)
• Asia Pacific (China, Japan, India, and the rest of the Asia Pacific region)
• Latin America (Brazil, Mexico, and the rest of Latin America)
• Middle East and Africa (GCC and rest of the Middle East and Africa)
𝗙𝗿𝗲𝗾𝘂𝗲𝗻𝘁𝗹𝘆 𝗔𝘀𝗸𝗲𝗱 𝗤𝘂𝗲𝘀𝘁𝗶𝗼𝗻𝘀?
Q1. What is the total market value of Migraine Drugs Market report?
Q2. Which are the top companies hold the market share in Migraine Drugs Market?
Q3. Which is the most influencing segment growing in the Migraine Drugs Market report?
Q4. What would be forecast period in the market report?
Q5. What is the market value of Migraine Drugs Market in 2020?
5933 NE Win Sivers Drive
#205, Portland, OR 97220
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
𝗔𝗯𝗼𝘂𝘁 𝗨𝘀 -
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
Pawan Kumar, the CEO of Allied Market Research is leading the organization toward providing high-quality data and insights. We are in professional corporate relations with various research data tables and confirms utmost accuracy in our market forecasting. Each and every us companies and this helps us in digging out market data that helps us generate accurate y data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Migraine Drugs Market: Key Findings, Executive Summary, Investment Pockets, and Regional Analysis | AMR here
News-ID: 2985687 • Views: 357
More Releases from Allied Market Research
Aromatherapy Market Size Exceed to Reach $5.3 Billion by 2031 | Medical segment …
According to a new report published by Allied Market Research, titled, "Aromatherapy Products Market," The aromatherapy products market was valued at $2.3 billion in 2021, and is estimated to reach $5.3 billion by 2031, growing at a CAGR of 9% from 2022 to 2031. Aromatherapy is the technique of using essential oils (EOs) and other fragrant molecules from plants to influence someone's mood or health. It is frequently linked to complementary
Modular Construction Market Demand, Industry Size, Growth Factor, Trends and For …
According to the report published by Allied Market Research, the global modular construction market generated $131.1 billion in 2021, and is estimated to reach $234.7 billion by 2031, witnessing a CAGR of 6.1% from 2022 to 2031. Benefits associated with products through modular construction market analysis is that it is easy to install, easy to transport, offers space constraints, and provide an aesthetic look. Modular construction used in marine transportation
Personal Cloud Market Size Driven by the Shift towards Personalized Digital Expe …
The personal cloud market size was valued at $26.80 billion in 2019, and is projected to reach $161.39 billion by 2027, growing at a CAGR of 24.6% from 2020 to 2027. Personal cloud services offer better storage, accessibility and sharing of user data along with enhanced security features. They have set up new standards for individuals to utilize the cloud computing services by offering better user experience and ease of use.
SSL VPN Market Size Accelerates as Organizations Embrace Zero Trust Architecture
The SSL VPN market size was valued at $4.6 billion in 2020, and is estimated to reach $12.6 billion by 2030, growing at a CAGR of 10.9% from 2021 to 2030. The global SSL VPN market is in its developing phase, and exhibits high growth potential, due to new features and services provided by the key players in the market. For instance, in March 2021, Cisco Systems, Inc., an American multinational
More Releases for Migraine
Digital Migraine Treatment Market: Size & Trends Shows a Rapid Growth by 2030- C …
A report was released recently that sheds lots of light on the Digital Migraine Treatment Industry. The report covers an overview of the Market along with a detailed explanation that provides a lot of insight. The report also analyzes the production as well as management technology in various end-user industries. An in-depth study in some new and prominent industry trends, analysis of the competition and regional analysis that is very
Rise in Prevalence of Migraine Drives the Migraine Drugs Market | Outlook 2025
Migraine is characterized by a recurrent throbbing headache, which affects only one side of the head. It is accompanied by vomiting, nausea and even altered vision in some cases. The increase in the prevalence of migraine, the rapid increase in the female population and the increased awareness among patients for the treatment and prevention of migraine are driving the growth of the global market for anti-migraine drugs. Get Access to TOC /
Migraine Therapeutics Pipeline Analysis -Results, Designation, Collaboration
Migraine is a type of a severe headache that is characterized by the intense throbbing in one area of the head. According to National Institute of Neurological Disorders and Stroke, migraine is three times common in women than in men and it is heralded by visual disturbances such as zig-zag lines vision and flashing lights. Access Report Overview: https://www.psmarketresearch.com/market-analysis/migraine-therapeutics-pipeline-analysis People having migraine generally have frequent attacks that cause, anxiety, stress,
Migraine KOL Interview
ReportsWorldwide has announced the addition of a new report title Migraine KOL Interview to its growing collection of premium market research reports. For a Detailed description and table of contents of this report please click here: https://www.reportsworldwide.com/report/biosimilar-insulin-market-access February 08, 2017 We interviewed a neurologist based in the US who specializes in headache medicine to gauge his current and anticipated future use of acute and prophylactic agents in the treatment of episodic
Migraine Disease Coverage Forecast and Market Analysis
ReportsWorldwide has announced the addition of a new report title Migraine Disease Coverage Forecast and Market Analysis to its growing collection of premium market research reports. For a Detailed description and table of contents of this report please click here: https://www.reportsworldwide.com/report/migraine-disease-coverage-forecast-and-market-analysis Introduction Migraine is a common, disabling, and recurring neurological disorder characterized by severe headache co-occurring with nausea, vomiting, and other symptoms, the duration of which can range from hours to days.
Global Anti-migraine Drugs Market to be Driven by Increasing Awareness Regarding …
A new market research study by Transparency Market Research provides a detailed analysis of the global market for anti-migraine drugs, including the major growth factors, barriers, product segmentation, current trends, major geographical segments, and competitive landscape. The research report, titled “Anti-Migraine Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019,” also presents the historical statistics and forecast figures to the readers, with the help